source
- FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer DrugsThe U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.fda press · 2mo ago↗ source
- #ASCO26: Bristol Myers details Phase 3 trial win for Pomalyst successorBristol Myers Squibb’s next-gen multiple myeloma drug cut the risk of disease progression or death for certain patients by 52% when added on top of a combination treatment regimen. The New Jersey p…Endpoints · 2mo ago↗ source
- David Chang to hand over the reins at Allogene; Ex-Esperion CEO gets started at PhlowLongtime Allogene CEO David Chang will be stepping down at the end of June. Chang has served as the company’s CEO for the past eight years and will be succeeded by ...